Ultrasound-based radiomics for the differential diagnosis of breast masses: A systematic review and meta-analysis
- PMID: 38606802
- DOI: 10.1002/jcu.23690
Ultrasound-based radiomics for the differential diagnosis of breast masses: A systematic review and meta-analysis
Abstract
Objectives: Ultrasound-based radiomics has demonstrated excellent diagnostic performance in differentiating benign and malignant breast masses. Given a few clinical studies on their diagnostic role, we conducted a meta-analysis of the potential effects of ultrasound-based radiomics for the differential diagnosis of breast masses, aiming to provide evidence-based medical basis for clinical research.
Materials and methods: We searched Embase, Web of Science, Cochrane Library, and PubMed databases from inception through to February 2023. The methodological quality assessment of the included studies was performed according to Quality Assessment of Diagnostic Accuracy Studies checklist. A diagnostic test accuracy systematic review and meta-analysis was performed in accordance with PRISMA guidelines. Sensitivity, specificity, and area under curve delineating benign and malignant lesions were recorded. We also used sensitivity analysis and subgroup analysis to explore potential sources of heterogeneity. Deeks' funnel plots was used to examine the publication bias.
Results: A total of 11 studies were included in this meta-analysis. For the diagnosis of malignant breast masses worldwide, the overall mean rates of sensitivity and specificity of ultrasound-based radiomics were 0.90 (95% confidence interval [CI], 0.83-0.95) and 0.89 (95% CI, 0.82-0.94), respectively. The summary diagnostic odds ratio was 76 (95% CI, 26-219), and the area under the curve for the summary receiver operating characteristic curve was 0.95 (95% CI, 0.93-0.97).
Conclusion: Ultrasound-based radiomics has the potential to improve diagnostic accuracy to discriminate between benign and malignant breast masses, and could reduce unnecessary biopsies.
Keywords: breast masses; diagnosis; meta‐analysis; radiomics; ultrasound.
© 2024 Wiley Periodicals LLC.
Similar articles
-
MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.Acad Radiol. 2024 Mar;31(3):763-787. doi: 10.1016/j.acra.2023.10.010. Epub 2023 Nov 2. Acad Radiol. 2024. PMID: 37925343
-
Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps.Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD012233. doi: 10.1002/14651858.CD012233.pub2. Cochrane Database Syst Rev. 2018. PMID: 30109701 Free PMC article.
-
Imaging modalities for characterising focal pancreatic lesions.Cochrane Database Syst Rev. 2017 Apr 17;4(4):CD010213. doi: 10.1002/14651858.CD010213.pub2. Cochrane Database Syst Rev. 2017. PMID: 28415140 Free PMC article.
-
Performance of radiomics analysis in ultrasound imaging for differentiating benign from malignant adnexal masses: A systematic review and meta-analysis.Acta Obstet Gynecol Scand. 2025 Aug;104(8):1433-1442. doi: 10.1111/aogs.15146. Epub 2025 May 1. Acta Obstet Gynecol Scand. 2025. PMID: 40312890 Free PMC article. Review.
-
Blood biomarkers for the non-invasive diagnosis of endometriosis.Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179. Cochrane Database Syst Rev. 2016. PMID: 27132058 Free PMC article.
Cited by
-
Diagnostic performance of contrast-enhanced ultrasound vs. conventional ultrasound for lymph node metastasis in patients with thyroid cancer: A meta-analysis.Oncol Lett. 2025 Jun 24;30(3):407. doi: 10.3892/ol.2025.15153. eCollection 2025 Sep. Oncol Lett. 2025. PMID: 40613033 Free PMC article.
-
Explanation and Elaboration with Examples for METRICS (METRICS-E3): an initiative from the EuSoMII Radiomics Auditing Group.Insights Imaging. 2025 Aug 13;16(1):175. doi: 10.1186/s13244-025-02061-y. Insights Imaging. 2025. PMID: 40802002 Free PMC article.
-
Clinical value of the nomogram model based on endoscopic ultrasonography radiomics and clinical indicators in identifying benign and malignant lesions of the pancreas.Front Oncol. 2025 Feb 19;15:1504593. doi: 10.3389/fonc.2025.1504593. eCollection 2025. Front Oncol. 2025. PMID: 40046629 Free PMC article.
References
REFERENCES
-
- Martin RF. Breast cancer. Surg Clin North Am. 2023;103(1):xiii‐xxiv.
-
- Clift AK, Hippisley‐Cox J, Dodwell D, et al. Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study. BMJ Open. 2022;12(3):e050828.
-
- Zhang H, Zhao T, Zhang S, et al. Prediction of axillary lymph node metastatic load of breast cancer based on ultrasound deep learning Radiomics nomogram. Technol Cancer Res Treat. 2023;22:15330338231166218.
-
- Zhu JY, He HL, Lin ZM, et al. Ultrasound‐based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis. Front Oncol. 2022;16(12):951973.
-
- Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early‐stage breast cancer. Nat Commun. 2020;11(1):1236.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical